107
Participants
Start Date
April 9, 2011
Primary Completion Date
August 5, 2022
Study Completion Date
August 5, 2022
Lactose (inactive placebo)
Placebo in an equivalent weight to midomafetamine HCl will be administered in identical appearing capsules during one of two experimental sessions. An equivalent to the initial and supplemental dose will exist.
midomafetamine HCl
120 mg midomafetamine HCl will be administered in opaque capsules at the outside of one of two experimental sessions, and upon mutual agreement between the investigator and participant, 40 mg may be administered 1.5 to 2.5 hours later.
Zen Therapeutic Solutions, Mt. Pleasant
Aguazul Bluewater, Inc., Boulder
Santa Fe MDMA Therapy Training, LLC, Santa Fe
Lead Sponsor
Lykos Therapeutics
INDUSTRY